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ABSTRACT 
 
INTRO: High fat diets (HFD) ingested over long periods of time have been shown to 
cause diet induced obesity leading to excessive adiposity and chronic low grade 
inflammation. Here we have shown how differing levels of saturated fats (SF), which are 
common storage fats, affect markers of inflammation and mitochondrial biogenesis. IL-
1β and TNF-alpha are pro-inflammatory cytokines that have been shown to increase with 
a HFD, while molecular signalers, PGC-1alpha, cyt c, and SIRT1, related to 
mitochondrial biogenesis have been shown to decrease. Despite the risks of consuming a 
diet high in SF’s, consumers continue to buy energy dense foods that are well known to 
cause metabolic dysregulation. METHODS: Male C57BL/6 mice were randomized into 
groups (n=8/9) (AIN 76 A), (AIN 76 A mod), (6% HFD), (12% HFD), (24% HFD). Mice 
were fed either HFD or LFD for 16 weeks. Body weights were measured weekly. At 20 
weeks of age mice were sacrificed and brain parts (hypothalamus, hippocampus, and 
cerebellum) were isolated for mRNA analysis of two inflammatory cytokines (IL-1β, 
TNF-alpha), and three molecular signalers (PGC-1alpha, SIRT1, and cyt c) using QT-
PCR. RESULTS: High fat feeding increased the accumulation of mass and obesogenic 
characteristics. Beginning at 12 weeks of age all HFD groups were different from control 
(AIN 76 A) (P<0.05). Beginning at 17 weeks of age the 12% HFD group was different 
from both the 6% and 24% HFD group. Gene expression of cyt c in the cerebellum 
increased in the 6% HFD relative to control (P < 0.033) and gene expression of IL-1β in 
the hypothalamus increased in the 12% HFD 
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group relative to control (P <0.031). CONLU: These findings suggest that diets high in 
saturated fat (6%, 12%, 24%), but the same in total fat (40%) leads to an increase in body 
weight and obesogenic characteristics, with the largest difference in the 12% HFD group. 
This was associated with increased IL-1β expression in the hypothalamus, while the 6% 
HFD was associated with an increase in cyt c expression suggesting changes in 
mitochondrial biogenesis in the cerebellum. 
Obesity; Metabolism; Brain; Inflammation
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CHAPTER 1 
THE EFFECTS OF A HIGH FAT DIET ON MITOCHONDRIAL BIOGENESIS 
AND INFLAMMATION IN THE BRAIN
1
                                                          
1
  L. Vervaecke, J.M. Davis, J. Carson, A. Murphy, and R. Thompson. To be submitted to Obesity. 
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INTRODUCTION 
Obesity has become a large scale epidemic spanning the globe affecting both 
adults and children causing severe health disparity and declines in quality of life. In the 
United States alone, more than one third of all Americans are overweight or obese and 
consume diets high in fat and excess calories (48). Many Americans suffer the ill-fated 
effects associated with obesity such as cardiovascular disease, atherosclerosis, 
hypertension, type 2 diabetes, fatty liver disease, and metabolic syndrome. The standard 
American diet consists of 52% carbohydrate intake, 15% protein intake, and 33% fat 
intake, of which 12% consists of saturated fats (SF) (23, 26). High fat diets (HFD) 
ingested over long periods of time are well known to cause increased adiposity and 
chronic low grade inflammation (37, 53).  SF’s are well known storage fats that have 
been linked to diet induced obesity and excessive adiposity thereby up regulating pro-
inflammatory pathways instigating insulin resistance and metabolic dysregulation (34). 
Despite the risks of consuming a diet high in SF’s, consumers continue to buy these 
energy dense foods that are well known to cause metabolic dysregulation.  
The majority of research that has assessed the effects of a HFD on mitochondrial 
biogenesis has been done in skeletal muscle and adipose tissue. We know that energy 
metabolism takes place in the mitochondria, the power house of the cell, and combines 
oxygen and desired fuel substrates, fats and carbohydrates, to be broken down into 
cellular energy in the form of adenosine triphosphate (ATP). These metabolic processes 
are regulated allosterically by adenosine monophosphate activated protein kinase 
(AMPK). AMPK is a regulator of mitochondrial biogenesis and is the primary pathway 
regulating mitochondrial activity (22, 65). AMPK mediates actions of peroxisome 
proliferator activated receptor gamma co-activator alpha (PGC-1alpha) and silent 
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information regulator one (SIRT1). SIRT1 acts by deacetylation of PGC-1alpha, a master 
regulator of mitochondrial biogenesis. SIRT1 has been shown to be a primary regulator 
of fatty acid oxidative metabolism and acts to protect against diet induced metabolic 
dysfunction (24).  
Current research has demonstrated that chronic HFD’s negatively affect 
mitochondrial capacity in skeletal muscle through dysfunctional enzymatic regulation 
and declines in the activity of molecular signalers (1, 58). HFD’s have also been shown 
to induce oxidative stress and insulin insensitivity in peripheral tissues (1, 10, 19, 27, 62, 
68). Chronic inflammation has been linked as a key component in diet induced obesity 
and has been shown to negate cellular interactions, insulin signaling, molecular signalers, 
and normal cellular functioning (1, 7, 19). Two pro-inflammatory cytokines IL-1β and 
TNF-alpha are responsible for activating the NFkB pathway inducing M1 macrophage 
infiltration (56). M1 macrophages activate pro-inflammatory cytokines and reactive 
oxygen species, which have been shown to cause mitochondrial collapse (25). A paucity 
of research has been done to elucidate the effects of HFD’s on skeletal muscle; however, 
there is a gap in understanding if similar molecular dysregulation in peripheral tissues is 
observed within the brain and potentially the cause of mitchondrial dysregulation, 
oxidative stress, and therefore cognitive impairment and central fatigue.  
 The apogee of the central nervous system (CNS) is the brain, which is composed 
of highly complex centers that are innervated by neurons, which control a plethora of 
activities including movement, metabolism, memory, information processing, problem 
solving, mood and fatigue (40, 64). Dysfunctional neurogenic activity has been 
associated with fatigue, psychological impairments and cognitive disorders (28, 43, 64, 
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70). Alzheimer’s disease and age related dementia are two disorders that have been 
correlated with diet induced obesity and have been the main focus of HFD studies in the 
brain (43, 70). Diets high in SF’s and cholesterol have demonstrated declines in the 
integrity of the blood brain barrier and severe gliosis throughout the hippocampus (21). 
Over nutrition has also been linked to increased inflammation in hypothalamic neurons 
(66). Recently it has been suggested that nutrient regulation by SIRT1 with a HFD was 
reduced in the hippocampus adversely affecting memory function (28, 72). Mitochondrial 
swelling has also been observed with an acute HFD and is believed to cause mitchondrial 
dysregulation; however, molecular signalers and specific mitochondrial markers were not 
analyzed (54).  
Skeletal muscle has been copiously researched regarding changes in 
mitochondrial capacity and inflammation with a HFD, but minute research is available 
observing if similar changes take place within the brain. Mitochondrial signalers have 
been shown to be important mediators in skeletal muscle metabolism, exercise 
performance, delayed onset of fatigue, and endurance capacity, but are peripheral and 
central activity similarly affected with a HFD? The purpose of this 16 week study was to 
determine the effect of diets high in saturated fat (6%, 12%, 24%), but the same in total 
fat (40%), on mitochondrial biogenesis and inflammation in the brain. Previous research 
in our lab has shown that a HFD of 12% SF, the most similar to the standard American 
diet, showed the greatest amount of adiposity, inflammation, and metabolic dysregulation 
in peripheral tissues (17). We hypothesize that a HFD consisting of 12% SF will reduce 
mitochondrial biogenesis and increase inflammation in the brain.  
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METHODS 
Animals 
Male C57BL/6 mice were bred and cared for in the animal facility at the 
University of South Carolina.   They were housed, four-five per cage, maintained on a 
12:12-h light-dark cycle in a low stress environment (22°C, 50% humidity, low noise) 
and given food and water ad libitum.  The Institutional Animal Care and Usage 
Committee of the University of South Carolina approved all experiments.   
Diets 
Experiment 1: At four weeks of age, mice were randomly assigned to 1of 5 
treatment diets (n=8-9/group): two control diets (CDs) (AIN-76A-1.6%-SF) (AIN-76A-
Mod-1.7%-SF) and three HFDs (6%-SF, 12%-SF, and 24%-SF) (BioServ, Frenchtown, 
NJ).The percentage of calories provided by each of the three macronutrients, the ratio of 
polyunsaturated: monounsaturated fatty acids (PUFA:MUFA), and the ratio of omega-
6:omega-3 fatty acids were identical for the HFDs and were designed to be similar to the 
standard American diet (26, 61). The second CD (AIN-76A-Mod) was used in order to 
match the PUFA: MUFA and omega-6: omega-3 ratios of the HFDs.      
Experiment 2: At four weeks of age mice were randomly assigned to 1 of 2 
treatment diets (n=5-9/group): HFD (12%) or CD (AIN-76A) (BioServ, Frenchtown, NJ). 
The percentage of calories provided by each of the three macronutrients, the ratio of 
PUFA: MUFA and the ratio of omega-6: omega-3 fatty acids were designed to be similar 
to the standard American diet (26, 61). 
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Body weights, food intake, and body composition 
 Body weight (BW) and food intake were monitored weekly (experiment 1 and 2). 
Body composition was assessed every four weeks (weeks 4, 8, 12, 16, and 20) 
(experiment 1 only). For this procedure, mice were placed under brief anesthesia 
(isoflurane) and were assessed for lean mass (LM), fat mass (FM), and body fat 
percentage (BF %) via dual-energy x-ray absorptiometry (DEXA) (Lunar PIXImus, 
Madison, WI).    
Tissue collection 
At 20 weeks of age, mice were sacrificed for tissue collection. The brain was 
dissected out into 7 sections: brain stem, cerebellum, cortex, frontal lobe, hippocampus, 
midbrain, and the hypothalamus. All tissues extracted were immediately snap-frozen in 
liquid nitrogen and stored at -80°C. Blood was collected from the inferior vena cava, and 
centrifuged at 4,000 rpm for 10 min at 4°C.  Plasma was aliquoted and stored at −80°C.   
mRNA expression 
 Brain tissue (n =8/9) were homogenized under liquid nitrogen with a Polytron 
(PT3100; Kinematica, Lucerne, Switzerland), and the quanidine thiocyanate method with 
TRIzol reagent (Life Technologies, GIBCOBRL, Carlsbad, CA) was used to extract total 
RNA. The extracted RNA (2.5ul of sample) was dissolved in diethylpyrocarbonate 
treated water and quantified spectrophotometrically at 260nm wavelength. The 260:280 
ratio was used to determine the quality of RNA; RNA with a ratio ˃ 1.6 was included in 
the analysis. RNA was reverse transcribed into cDNA in a 50ul reaction volume 
containing 19.25ul RNA (1.5ug) in RNase-free water, 5ul 10X RT buffer, 11ul 25mM 
MgCl2, 10ul deoxy-NTP mixture, 2.5ul random hexamers, 1ul RNase inhibitor, and 
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1.25ul multiscribe reverse transcriptase (50U/ul). Reverse transcription was completed at 
25°C for 10 min, 37°C for 120 min, and 85°C for 5 min, followed by a quick chilling on 
ice. Samples were stored at -20°C until subsequent amplification. 
Quantification of real time PCR 
 Real time PCR analysis was carried out per manufacturer’s instructions (Applied 
Biosystems, Foster City, CA) using TaqMan Gene Expression Assays. Amplification of 
DNA as performed in 12.5ul TaqMan Universal PCR Master Mix (AmpliTaq Gold DNA 
Polymerase, Passive Reference 1. Buffer, dNTPs; AmpEase UNG), 1ul cDNA, 9ul 
RNase-free water, 1.25ul 18S primer (VIC), and 1.25ul primer (FAM) (for endogenous 
references and target gene) in a final volume of 25ul/well. A MicoAmp 96 well reaction 
plate was loaded with samples and run using an ABI Sequence Detection System. 
Following 2 min at 50°C and 10 min at 95°C, plates were coamplifed by 40 repeated 
cycles, with one cycle consisting of a 15-s denaturing step at 95°C and a 1 min 
annealing/extending step at 60°C. The data were analyzed by ABI software using the 
cycle threshold (CT), or the value calculated and based on the time at which the reported 
fluorescent emission increases beyond a threshold level citing the cycle number at which 
the cDNA amplification was first detected. 
Quantification of mRNA expression  
 PGC-1alpha, SIRT1, cyt c, IL-1β, TNF-alpha expression were calculated using a 
single calibrator sample to compare every known samples gene expression against. 
Breifly, ∆CT [CT (FAM) – CT (VIC)] was calculated for each sample and the average ∆CT 
of the control mice was then used as the calibrator sample. Initial exclusion criteria 
consisted of FAM CT ≥ 40 and VIC CT ≤ 23 and results showed all samples CT values 
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were VIC CT ≤15, and FAM CT ≥ 33. This analysis and quantification method has been 
shown to yield similar results as the standard curve method. 
Statistical analysis 
Data regarding mitochondrial markers and inflammatory markers were analyzed 
using a one-way analysis of variance (ANOVA) to observe changes between all groups. 
Student Newman Keuls post hoc test was used to make comparisons where appropriate. 
All data were analyzed using commercial software (SigmaStat, SPSS, Chicago, IL). 
Statistical significance was set with an alpha value of P < 0.05. Data are presented as 
mean (±SEM). 
RESULTS 
 
Diets  
 Mice were housed 4-5/ cage and caloric intake was assessed by the total amount 
of food eaten divided by the number of mice per cage. Food and water intake was 
measured weekly. In general, all HFD groups consumed similar food and water intake 
throughout the 16 weeks of feeding relative to control. 
Body weights 
 Body weights were measured weekly to determine changes in total body weight in 
regards to the differing ratios of saturated fat in the diet [Figure 1.1]. Body weight 
measurements taken show that HFD increases the accumulation of mass and obesogenic 
characteristics. Beginning at 12 weeks of age all HFD groups were different from control 
(AIN 76 A) (P<0.05). Beginning at 13 weeks of age all HFD groups were different from 
control (AIN 76 A mod) (P<0.05). By weeks 17-20 the 12% HFD group was 
significantly greater in weight from both 6% HFD and 24% HFD (P<0.05). 
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Gene expression for mitochondrial biogenesis 
 Gene expression of SIRT1, PGC-1alpha, and cyt c were examined in the 
hypothalamus, hippocampus, and cerebellum portions of the brain. PGC-1alpha 
expression showed no differences between groups in all three portions of the brain 
[Figure 1.2]. SIRT1 expression was measured in the hippocampus and cerebellum, but 
not in the hypothalamus due to limited reagents. Despite changes observed in the 
literature with HFD, no significant differences were found between groups [Figure1.3]. 
When examining cyt c, we found an increase in gene expression within the 6% HFD 
relative to control (AIN 76 A) (1.64±0.28) vs. (1.00±0.07) (P <0.033), but no differences 
were seen in cyt c gene expression in the 12% and 24% HFD relative to control [Figure 
1.4]. We measured two markers of mitochondrial biogenesis including SIRT1 and PGC-
1alpha, which are molecular signalers involved in stimulating mitochondrial biogenesis 
and also cyt c, which is an enzyme in the electron transport chain associated with 
mitochondrial adaptation. Overall it was shown that the metabolic signalers associated 
with mitochondrial biogenesis were not significantly altered by16 weeks of high fat 
feeding, however, unexpectedly, cyt c was increased with high fat feeding only in the 
cerebellum. 
Gene expression for inflammation 
Gene expression of IL-1β and TNF-alpha were examined in the hypothalamus, 
hippocampus, and cerebellum regions of the brain. TNF-alpha expression showed no 
significant group differences in any of the three brain regions [Figure1.6]. However, IL-
1β a mediator of TNF-alpha through IL-1 receptor signaling, which activates the NFkB 
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pathway, was found to be significantly higher in the 12% HFD group compared to 
control (AIN 76 A) (2.108±0.330) vs. (1.00±0.06) (P < 0.031) [Figure 1.5]. 
DISCUSSION 
  
It has been well established that diet induced obesity by HFD is commonly 
associated with increased risk of cardiovascular disease, diabetes, and many other 
pathologies due to the accumulation of adipose tissue leading to chronic inflammation, 
thereby causing metabolic dysregulation. Skeletal muscle has been copiously researched 
to elucidate the extent of oxidative stress, fatigue, inflammation, and metabolic 
dysregulation, however, the brain is still poorly understood in regards to these same 
developments. The purpose of this 16 week study was to determine the effect of diets 
high in SF (6%, 12%, 24%), but the same in total fat (40%), on mitochondrial biogenesis 
and inflammation in the brain. In general all HFD groups increased in size and body 
mass; however, the 12% HFD group showed an increase in mass independent of the 6% 
and 24% HFD group [Figure 1.1]. Previous research in our lab has shown that a diet of 
12% SF, the most similar to the standard American diet, observed the greatest amount of 
adiposity, inflammation, and metabolic dysregulation in peripheral tissues (17). Despite 
similar characteristics in function between central and peripheral tissues, the brain shows 
disparate outcomes in inflammation and mitochondrial capacity with a HFD. Our primary 
finding was that the 12% HFD causes an increase in IL-1β expression in the 
hypothalamus; a primary regulator of metabolism. 
The first aim of our study was to elucidate how differing ratios of SF (6%, 12%, 
24%) affect mitochondrial biogenesis in the brain. To do this we examined changes in 
expression of two molecular signalers, SIRT1 and PGC-1alpha, and cyt c, an important 
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enzyme in the electron transport chain. Several studies have worked to examine the 
effects of a diet high in fat on mitochondrial capacity in the brain; however, no studies 
have been completed to determine, more specifically, how diets high in SF affect similar 
variables. Brain HFD research has been primarily focused on Alzheimer’s disease and 
age related dementia with the aim to determine how chronic ingestion of a HFD affects 
memory consolidation and information processing. Recently it was shown that 23 weeks 
of high fat feeding with 60% kcal coming from fat causes a decline in SIRT1 gene 
expression in the hippocampus suggesting a decrease in mitochondrial biogenesis and a 
subsequent decline in hippocampus-dependent memory (28). In discordance, our results, 
after 16 weeks of high fat feeding with 40% kcal coming from fat and differing ratios of 
SF (6%, 12%, 24%), show no change in SIRT1 across all groups [Figure 1.3].  Based on 
previous research in our lab, we expected to see a decline in SIRT1 gene expression 
within the 12% HFD, as we have shown it be the most metabolically dysregulating in 
peripheral tissues (17). However, it is difficult to compare current literature citing a 
change in SIRT1 gene expression due to differences in study duration; 16 versus 23 
weeks, and diet composition; 40% versus 60% kcal (28). 
 We also assessed central mitochondrial biogenesis by examining changes in the 
expression of PGC-1alpha. Our results show no change in PGC-1alpha with a 16 week 
HFD [Figure 1.2]. Extensive literature is available regarding changes in PGC-1alpha in 
skeletal muscle with a HFD; however, there are few studies that have looked similar 
changes in the brain. Richardson et al. 2005 shows a decline in PGC-1alpha expression in 
muscle tissue post 2 day lipid infusion (20% triglyceride emulsion, 30% kcal) in human 
subjects (58). Although an 8 week intervention in mice suggests that a high fat feeding 
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with 47% kcal coming from fat, does not impede mitochondrial biogenesis, but in fact 
enhances it with an increase in PGC-1alpha expression (29). In accordance with our 
findings in the brain, Draznin et al. 2012 found no change in PGC-1alpha or other 
mediators of mitochondrial biogenesis in skeletal muscle with a HFD (50%  kcal) (16), 
suggesting that duration and diet composition are major limitations to observing 
mitochondrial changes with the induction of a HFD.  
Cyt c was the final marker of examination to determine changes in mitochondrial 
biogenesis. Cyt c is a component of the electron transport chain that is commonly used to 
observe mitochondrial adaptations (39). Our results show an increase in cyt c expression 
within the cerebellum of the 6% HFD group compared to control [Figure 1.4], suggesting 
that mitochondrial biogenesis was increased with a HFD. However, we believe that this 
may be an extraneous effect of medium versus long chain fatty acid breakdown, due to 
the fact that no changes were observed in cyt c in the higher saturated fat groups; the 12% 
HFD and the 24% HFD. Medium chain fatty acids are quickly transported and oxidized 
within the body compared to long chain fatty acids, which are less efficiently oxidized 
and more likely to be stored as adipose tissue (46). 
 There is a known link between diet induced obesity and systemic inflammation 
and it has been suggested that central inflammation may be related to the development of 
Alzheimer’s disease and age related dementia by neuronal dysfunction. The final aim of 
our study was to examine how diets high in SF (6%, 12%, 24%) affect inflammation in 
various regions of the brain. To our knowledge only one published study has reported 
changes in the brain due to a diet high in SF. Findings describe alterations in the integrity 
of the blood brain barrier of the hippocampus with increased microgliosis in HFD fed 
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mice (45% kcal) (21). In addition Thaler et al. 2012 has shown that diet induced obesity 
(60% kcal) causes inflammation in the brain with only 4 days of high fat feeding, where 
as it takes weeks to observe inflammation in muscle (66, 67). Our results show an 
increase in IL-1β in the hypothalamus in the 12% HFD group after 16 weeks of high fat 
feeding, however, no changes were seen in the hippocampus or the cerebellum 
[Figure1.5].  
 IL-1β mediates the up regulation of many other inflammatory cytokines like TNF-
alpha through IL-1 receptor signaling subsequently activating the NFkB pathway (45). 
NFkB works to increase systemic lipolysis and glycogenolysis thereby increasing free 
fatty acids and glucose in the blood that chronically results in insulin resistance. Despite 
changes in IL-1β expression in the hypothalamus, we did not observe changes in TNF-
alpha expression across all groups in any of the examined brain parts. With regards to the 
development of severe pathology related to diet induced obesity, such as metabolic 
syndrome, the NFkB pathway is activated by low grade inflammation and chronically 
orchestrates M1 machrophage infiltration that increases pro-inflammatory cytokines such 
as TNF-alpha and  IL-1β, as well as reactive oxygen species (56). This positive feedback 
loop of inflammation has been shown to cause mitochondrial damage and collapse as 
well as cellular apoptotic responses (25). The severity of the injury will dictate the time 
frame in which inflammatory cytokines are up regulated, some injuries necessitate more 
time than others. 
In conclusion, this is the first study to examine the effects of differing levels of 
SF’s on mitochondrial biogenesis and inflammation in the brain. We can conclude that 
diets high in SF (6%, 12%, 24%), but the same in total fat (40%) lead to an increase in 
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body weight and obesogenic characteristics, with the largest difference in the 12% HFD 
group, which was associated with increased hypothalamic IL-1β expression, a marker of 
inflammation. The 6% HFD group was associated with changes in mitochondrial 
biogenesis in the cerebellum. It should be taken into consideration that in this study and 
others, these responses are highly dependent upon the amount of SF in the diet and total 
calories from fat. Limitations in this study include duration of the HFD and diet 
composition. This study has provided a basic understanding of how diets high in SF 
affect mitochondrial biogenesis and inflammation in the brain, future research is 
warranted to determine specific timelines in which mitochondrial biogenesis is affected 
along with changes in the normal inflammatory response. 
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Figure 1.1: The effect of diets high in saturated fat on body weight. Body weights 
were measured weekly and are reported from 4 weeks of age to 20 weeks of age. AIN 76 
A (n=8), AIN 76 A mod (n=9), 6% HFD (n=9), 12% HFD (n=9), and 24% HFD (n=8). 
&Significantly different from AIN 76 A mod, P <0.05 (weeks 11-12, 12% HFD only) 
(weeks 13-20, 24%, 12%, 6% HFD). *Significantly different from AIN 76 A, P<0.05 
(week 11, 12% HFD only) (weeks 12-20, 24%, 12%, 6% HFD). %Significantly different 
from 6% HFD, P<0.05 (weeks 15, 17-20, 12% HFD only). $Significantly different from 
24% HFD, P<0.05 (weeks 17-20, 12% HFD only). 
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Figure 1.2: The effect of saturated fat on PGC-1alpha gene expression in HFD fed 
mice. Gene expression (PGC-1alpha) for all groups is reported from the time of sacrifice, 
20 weeks of age. AIN 76 A (Con n=6), AIN 76 A mod (Con n=6), 6% HFD (6% n=6), 
12% HFD (12% n=6), 24% HFD (24% n=6). No significant differences were found. 
Values are reported as mean ± SE. 
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Figure 1.3: The effect of saturated fat on SIRT1 gene expression in HFD fed mice.        
Gene expression (SIRT1) for all groups is reported from the time of sacrifice, 20 weeks 
of age. AIN 76 A (Con n=6), AIN 76 A mod (Con n=6), 6% HFD (6% n=6), 12% HFD 
(12% n=6), 24% HFD (24% n=6). No significant differences were found. Values are 
reported as mean ± SE. 
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Figure 1.4: The effect of saturated fat on CYT C gene expression in HFD fed mice.  
Gene expression (cyt c) for all groups is reported from the time of sacrifice, 20 weeks of 
age. AIN 76 A (Con n=6), AIN 76 A mod (Con n=6), 6% HFD (6% n=6), 12% HFD 
(12% n=6), 24% HFD (24% n=6). *Significantly different from the control diet (AIN 76 
A), P<0.05. Values are reported as mean ± SE. 
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Figure 1.5: The effect of saturated fat on IL-1beta gene expression in HFD fed mice.  
Gene expression (IL-1beta) for all groups is reported from the time of sacrifice, 20 weeks 
of age. AIN 76 A (Con n=6), AIN 76 A mod (Con n=6), 6% HFD (6% n=6), 12% HFD 
(12% n=6), 24% HFD (24% n=6). *Significantly different from control diet (AIN 76 A), 
P<0.05. Values are reported as mean ± SE.  
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Figure 1.6: The effect of saturated fat on TNF-alpha gene expression in HFD fed 
mice. Gene expression (TNF-alpha) for all groups is reported from the time of sacrifice, 
20 weeks of age. AIN 76 A (Con n=6), AIN 76 A mod (Con n=6), 6% HFD (6% n=6), 
12% HFD (12% n=6), 24% HFD (24% n=6). No significant differences were found. 
Values are reported as mean ± SE.
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CHAPTER 2 
THESIS PROPOSAL 
BRIEF RATIONAL 
More than one third of all Americans are overweight or obese and consume diets 
high in saturated fat, many of which suffer the ill-fated effects associated with obesity 
such as hypertension, type 2 diabetes, and metabolic dysfunction. Energy metabolism in 
the form of cellular respiration takes place in the mitochondria, the power house of the 
cell, and combines oxygen and fuel sources such as fats, carbohydrates, and proteins to 
be catabolized into cellular energy in the form of adenosine triphosphate (ATP). All 
metabolic functions require the use of ATP to sustain activity and to carry out daily 
processes. Muscle being a highly plastic organ can store fats and carbohydrates as 
intramuscular triglycerides (IMTG) and glycogen. The standard American diet consists of 
52% carbohydrate intake, 15% protein intake, and 33% fat intake of which 12% consists 
of saturated fat. Sparks et al. 2006 has elucidated that diets high in saturated fat and 
overall total fat have negative effects on energy metabolism in skeletal muscle 
mitochondria related to dysfunctional enzymatic regulation and mitochondrial biogenesis, 
as well as gene expression controlling glucose metabolism and storage. Chronic 
inflammation related to obesity has also been shown to negate cellular interactions, 
insulin signaling, enzymatic regulators, and normal cellular functioning.  However, 
minute research has been completed observing if similar changes take place within the 
brain.
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The apogee of the central nervous system (CNS) is the brain, which is composed 
of highly complex centers that control processes like movement, sight, hearing, emotions, 
and metabolism. The hypothalamus, hippocampus, motor cortex, cerebellum, and brain 
stem are the primary controllers of these bodily functions. Glucose being the primary fuel 
source within the CNS is responsible for neurogenic activity. Astrocytes are glial cells 
that are positioned between blood vessels and neurons that control energy metabolism in 
the brain by feeding glucose to neurons. Neurons within the CNS control a plethora of 
activities including attention, memory, information processing, problem solving, 
impaired mood, and fatigue. Dysfunctional neurogenic activity has been associated with 
fatigue, psychological impairments, and cognitive disorders related to malfunctions 
within the astrocytes in the hypothalamus and the hippocampus, but what is causing this.  
To date skeletal muscle has been highly researched regarding changes in 
mitochondrial activity and glycogen storage with the manipulation of a high fat diet, but 
minute research has been completed observing if similar changes take place within the 
brain. Mitochondria and glycogen, as well as their subsequent regulators, have been 
shown to be important mediators in skeletal muscle regarding energy metabolism and 
endurance capacity, but are peripheral and central activity similarly affected with a high 
fat diet?
PURPOSE AND SPECIFIC AIMS 
The purpose of this 16 week study was to determine the effect of diets high in 
saturated fat (6%, 12%, 24%), but the same in total fat (40%), on mitochondrial 
biogenesis and inflammation in the brain. Previous research in our lab has shown that a 
diet of 12% saturated fat, the most similar to the standard American diet, observed the 
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greatest amount of adiposity, inflammation and metabolic dysregulation in peripheral 
tissues. 
Aim1: To determine the effects of a high fat diet (6%-SF, 12%-SF, 24%-SF) and 
(40%) total fat on mitochondrial biogenesis in the brain. 
 We hypothesize that a high fat diet of 12%-SF will reduce mitochondrial 
biogenesis in the brain. We will use RNA isolation and real time PCR to measure gene 
expression of PGC-1alpha, SIRT1, and cytochrome c in the hippocampus, hypothalamus, 
and cerebellum.  
Aim 2: To determine the effects of a high fat diet (12%-SF) and (40%) total fat on 
inflammation in the brain. 
We hypothesize that a high fat diet of 12%-SF will increase inflammation in the 
brain. We will use RNA isolation and real time PCR to measure gene expression of IL-1β 
and TNF-alpha in the hippocampus, hypothalamus, and cerebellum.
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PROPOSED MODEL 
                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: This study is aimed to uncover the proposed model of a diet high in saturated 
fat (6%, 12%, 24%), but the same in total fat (40%) on the effects of mitochondrial 
biogenesis and inflammation in the brain. Based on previous research it is theorized that 
the 12% saturated fat diet, the diet most similar to the standard American diet, will 
observe the most mitochondrial dysfunction related to changes mitochondrial signaler 
regulation in combination with increased inflammation and neuronal injury therefore 
potentiating CNS impairment.
High Fat Diet 
6%-SF, 12%-SF, 24%-SF 
 
 
Increased 
inflammation, 
reactive O2 species  
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mitochondrial 
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LITERATURE REVIEW 
Energy Metabolism 
Metabolism is the summation of all cellular work occurring at random within the 
body, but more specifically, energy metabolism is a cyclic response of turnover and 
synthesis to sustain usable energy (40). Cellular energy can be derived in two ways: 
through aerobic pathways or anaerobic pathways. Anaerobic pathways are up regulated at 
the beginning of all activity and do not use oxygen to synthesize cellular energy (39). 
However, the aerobic pathway is a high capacity energy producer that utilizes oxygen to 
combust fuels for energy (39).  Fuel sources for energy metabolism are derived from 
three major sources, fats, carbohydrates, and proteins, each source acting in cooperation 
with the others to sustain bodily function. These macromolecules in combination with 
oxygen in the aerobic pathway are transported to the mitochondria, the power house of 
the cell, to be combusted into usable energy in the form of adenosine triphosphate (ATP) 
(3). 
 Dependent upon cellular energy demands desired substrates will be selected to 
form ATP. Carbohydrates are the primary fuel source during intense exercise and there 
stored form as glycogen acts as a metabolic regulator for fatigue, while fats and proteins 
are the desired fuel sources at rest (39). Energy substrates travel within the blood stream 
until extraction or deposition occurs. Glucose can be extracted from the blood via insulin 
or by cellular glucose transporters (GLUT) (68).  Fatty acids bind to carrier
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proteins in the blood, like albumin or even insulin, and are transported to the cell for 
utilization or storage (39). Fats and carbohydrates work cooperatively to maximize 
energy production. Fats are oxidized in a residual carbohydrate metabolism allocating 
glycogen sparing; therefore delaying the onset of fatigue (39). Protein degradation for 
ATP synthesis is only used in highly fasted states. All substrates can be combusted for 
the production of cellular energy or they can be stored within the body for later usage in 
common sites such as: skeletal muscle, adipose tissue, liver, and the brain. However, 
substrate utilization and storage are highly regulated by metabolic enzymes on a minute 
by minute basis. 
 Regulation 
 Storage and utilization of energy substrates is dependent upon cellular energy 
demand and subsequent metabolic regulating pathways. Adenosine monophosphate 
activated protein kinase (AMPK) acts as a local energy sensor and regulates 
mitochondrial biogenesis and overall metabolism through allosteric mechanisms (8, 16, 
40). Allosteric regulation of metabolism is controlled through AMPK based on a 
continuum of caloric intake from a fed state to a fasted state and on cellular energy levels 
meaning, when energy levels are low the AMPK pathway is activated and when energy 
levels are high AMPK activity declines. Peroxisome proliferator activated receptor 
gamma coactivator alpha (PGC-1alpha) and sirtuins one (SIRT1) are key signaling 
molecules that are allosterically mediated within the AMPK pathway that intrinsically 
regulates mitochondrial activity and mitochondrial biogenesis. In a fasted state the 
AMPK pathway is activated by the release of glucagon thereby stimulating SIRT1 via 
cAMP cascade, which deacetylates PGC-1alpha, increasing fatty acyl CoA 
27 
 
dehydrogenase and carintine acyletransferase, driving mitochondrial biogenesis and 
oxidative capacity of long and short chain fatty acids (1, 16, 50). PGC-1alpha is 
considered to be a “master regulator" of mitochondrial biogenesis in skeletal muscle and 
has been shown to up regulate fatty acid metabolism and energy expenditure within the 
mitochondria, as well as to improve insulin sensitivity in times of stress (22, 65). SIRT1 
and PGC-1alpha acting in corporation enhance fatty acid metabolism by increasing the 
gene expression of metabolites used in oxidative metabolism, however, fat metabolism 
has been shown to be down regulated in SIRT1 knockout models citing the requirement 
of SIRT1 for mitochondrial oxidative capacity (22). Cytochrome c (cyt c) and citrate 
synthase (CS) are two mitochondrial molecular signalers that reside within the inner 
membranes of the mitochondria and electron transport chain (ETC) and dictate metabolic 
energy flow through electron acceptance during oxidative metabolism (39). When 
metabolic demand increases chronically, as with exercise training, mitochondria are 
stimulated for local division increasing mitochondrial density, which can be observed by 
expression of mitochondrial DNA (mtDNA). Regulation of metabolism can be affected 
by various external stimuli including exercise and diet. Diets high in fat leading to 
obesity have been shown to negatively affect enzymatic regulation and cause metabolic 
dysfunction. 
High fat diets 
Over the last 20 years, across all age groups, obesity rates have risen due to lack 
of daily physical activity and the over consumption of energy dense foods. In 2010 the 
United States had more than 1/3 of all adult Americans classified as obese with a body 
mass index (BMI) greater than or equal to 30kg/m2 (48).The standard American diet 
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consists of 52% carbohydrate, 15% protein, 33% fat with 12% coming from saturated fat, 
a ratio of 1.8 to 1 monounsaturated to polyunsaturated fat, and a ratio of 20 to 1 omega 6 
to omega 3 (23, 26, 61). In 2013 the trend for obesity continues as the amount of 
saturated fat intake increases. Saturated fats (SF), commonly referred to as palmitic and 
stearic acid, are known storage fats that are linked to dietary obesity and excessive 
adiposity. Foods high in SF include red meats, many dairy products like cheese and 
whole milk, pork, fast food and processed foods (69). SF’s have been shown to instigate 
pro-inflammatory pathways via NFkB and can cause insulin resistance and dysregulation 
in metabolic enzymes (34). Many side effects of diets high in saturated fat have been 
linked to fatty liver disease, diabetes, cardiovascular disease, hypertension, metabolic 
syndrome and many other health disparities.  
Other types of HFD’s include polyunsaturated fat diets (PUFA) and 
monounsaturated fat diets (MUFA). PUFA’s, particularly omega-6 and omega-3, are 
related to healthy fat intake by consuming foods such as fish, soy products, and nuts (57). 
MUFA’s are similar to PUFA’s compositionally, but MUFA’s can be obtained through 
oils such as canola and olive (23). MUFA’s have been shown to attenuate the effects of a 
diet high in saturated fat, but negates normal metabolic activity when combined with high 
PUFA diets (23).  
 Researchers are now comparing similar diets in animal and human models to 
represent the population to determine how local diets are affecting energy metabolism. A 
predominate amount of calories are proportioned from fats to observe similar caloric 
intake patterns of the standard American to determine if a HFD has any effect on energy 
metabolism and substrate utilization. Diets consisting of 35-40% fat are commonly used 
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and have been shown to attenuate insulin sensitivity (41) therefore leading to declines in 
glycogen synthesis (10) and metabolism of fatty acids by PCG-1alpha stimulation (65).  
Overall, it has been shown that excessive fat intake is linked to serious metabolic 
dysregulation in the body, with lipid accumulation causing oxidative stress within the cell 
leading to declines in glucose uptake, pre-empting fatigue (58, 60, 71). Excessive lipid 
accumulation by a HFD over stimulates the cell causing increased reactive oxygen 
species (ROS), thereby causing oxidative stress and increasing inflammation potentially 
leading to dysfunctional enzymatic and molecular signaling activity. This phenomenon 
has been highly researched in skeletal muscle. 
High Fat Diet and Skeletal Muscle 
Skeletal muscle is the primary location for oxidative metabolism of glucose and 
lipid substrates, which also makes it a prime location to experience metabolic 
dysregulation during times of stress. HFD’s can act as a metabolic stressor by inducing 
an overload on the body with excess lipid accumulation and altered signaling of AMPK 
(1, 19) causing localized oxidative stress and fatigue. Diets high in SF have been shown 
to impair insulin sensitivity and enzyme regulation by causing severe inflammation 
through the NFKB pathway increasing inflammatory cytokines IL-6 and TNF-alpha (32, 
33). Diets high in SF have also been shown to decrease PGC-1alpha activity thereby 
reducing oxidative phosphorylation of lipids (11, 34). AMPK and PGC-1alpha gene 
expression have been shown to increase with the acute manipulation of a HFD and 
concomitantly SIRT1 gene expression is up regulated to enhance fatty acid metabolism 
during times of metabolic stress, thereby increasing mitochondrial biogenesis driving 
energy metabolism in times of low demand (1, 19, 22).  
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However, long term manipulations of a HFD have shown the opposite effects on 
AMPK, with a decline in activity (24). Chronic ingestion of a high fat diet is well known 
to cause insulin insensitivity. With reduced glucose uptake by insulin, glycogen synthesis 
in skeletal muscle is reduced potentially leading to metabolic fatigue. Therefore, with 
chronic lipid accumulation both carbohydrate and lipid uptake are halted and 
subsequently reduced by obesity related insulin insensitivity; that may be correlated with 
inflammation (27, 51, 68). Cleasby et al. 2011 has demonstrated with a five week HFD in 
mice, a reduction in both insulin sensitivity and glycogen synthesis in skeletal muscle 
(10). Sparks et al. 2006 found a similar response in a three week HFD study (62). 
Previous research completed in our lab has shown that 16 weeks of a high fat diet with 
12% saturated fat, the most similar to the standard American diet, shows the greatest 
amount of adiposity, inflammation, and subsequent metabolic dysregulation in peripheral 
tissues (17). Through extensive review of the literature it can be noted that the effects of a 
HFD on skeletal muscle metabolism and enzymatic regulation has been well researched, 
however,  results have yet to be definitively addressed. 
Differences in Metabolic Function 
 Oxidative phosphorylation has been shown in several studies to be affected by the 
manipulation of a HFD; some studies cite an increase in mitochondrial oxidative capacity 
with increased lipid availability, while others cite the reverse effects. Length of the 
manipulation, the amount of SF, the total amount of fat intake, and molecular makeup of 
fat are potential parameters affecting the dichotomous outcomes. Iossa, S. et al. 2002 
demonstrated that two weeks of a HFD enhanced mitochondrial oxidative capacity 
utilizing lipids as the primary fuel source (30). Lionette, L. et al. 2007 and Hoeks, J. et al 
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2008 observed similar findings in a seven and eight week HFD study respectively (29, 
38). Lionette used 50% energy intake from lipids with a PUFA to saturated fat ratio of 
1.7 (38) and Hoeks used 47% energy intake coming from lipids (29). However, longer 
manipulations of a high fat diet have elucidated the reverse effects. Enos et al. has shown 
that 16 weeks of a high fat diet with 40% energy intake coming from lipids and 12% 
saturated fat shows the greatest amount of adiposity and subsequent metabolic 
dysregulation, disparately saturated fat amounts independent of total fat shows the 
opposite effects with 24% saturated fat displaying the lowest levels of metabolic 
dysregulation and even normal mitochondrial function (17). Enos and colleges state a 
potential mechanism in molecular differences between long and short chain fatty acids. 
Gomes et al. completed a 12 week HFD study and found declines in mitochondrial 
enzymatic and molecular signaling activity, but used a similar diet to Lionette and 
colleges at 60% energy intake coming from lipids (24). This finding suggests that length 
of the HFD and chronic ingestion of lipids is the main contributor to metabolic syndrome. 
However, these dichotomous outcomes related to duration of study and amount of total 
fat and SF have not been thoroughly explained in the literature and future research is 
warranted.  
In summary current research has shown with the manipulation of a HFD that 
regulation of AMPK becomes dysfunctional subsequently altering allosteric regulation of 
PGC-1alpha, SIRT1, and insulin decreasing homeostatic metabolic function in skeletal 
muscle. Excessive lipid accumulation causes oxidative stress on the cell affecting normal 
metabolism of fuel substrates. Chronically glucose and lipid substrate utilization and 
storage becomes impaired and mitochondrial biogenesis declines. There is copious 
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evidence displaying the negative effects of a HFD on skeletal muscle metabolism, 
however, we have yet to elucidate how metabolism and mitochondrial biogenesis is 
affected with a HFD in the central regulator of our body, the brain. 
Brain  
 The brain is the apogee of the CNS and is divided into white and grey matter in 
four primary lobes: occipital, temporal, frontal, and parietal, which are then divided into 
smaller subsections (40). The subsections are responsible for controlling complex 
processes involving motor function, decision making, metabolism, mood, information 
processing, and regulating energy and fatigue through neuronal communication (40). The 
medulla oblongata and pons are regions of the brain stem. Both regions control motor and 
sensory function in the body. The medulla oblongata specifically controls autonomic 
responses including respiratory, cardiovascular and digestive functioning (40). The 
hippocampus is part of the limbic system that involves memory storage and information 
retrieval (40). The cerebellum controls bodily movement; consciously and 
subconsciously (40).The hypothalamus is the central regulator of all metabolism 
controlling hunger and thirst in “feeding centers” and “satiety centers” with hormonal 
responses that can stimulate glucose and lipid uptake, utilization, and storage (6).  
The brain utilizes and stores energy substrates to carry out basic daily processes. 
Contrary to skeletal muscle, the brain does not metabolize lipids as an energy substrate, 
but growing evidence sites the “sensing” of fatty acids to dictate hormonal signaling (36, 
57). Glucose is the primary energy substrate in the brain that is utilized by neurons and 
stored in astrocytes, which accounts for 99% of all ATP production (20, 55). Astrocytes 
are connected to neurons by capillary networks that allow glucose to move freely for 
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energy usage. Similar to skeletal muscle, the brain uses GLUT receptors, specifically 
GLUT1, 3, to transport glucose from the blood across the neuronal membrane for direct 
utilization by the neuron or storage in the astrocyte where glycogen is primarily localized 
(14, 15, 55).  Astrocytic glycogen is the only source of glycogen storage in the brain, but 
compared to skeletal muscle storage is insignificant (15).  
The brain functions primarily under aerobic metabolism using mitochondria to 
oxidize glucose for energy due to the limited glycolytic capacity of the CNS (9, 43). 
Neuronal stimulation is activated via sodium release, coupled by glutamine reuptake, 
which stimulates glucose metabolism in the brain (55). Brain glucose metabolism in 
neurons is regulated via AMPK, which mediates molecular signaling of SIRT1 and PGC-
1alpha, thereby regulating insulin (74). AMPK also moderates nutrient usage and 
hormonal regulation (4, 42).  
Hormone release, regulated by the hypothalamus, contributes stimulatory affects 
to the uptake, storage, and utilization of glucose under different physiological states. In a 
stressful physiological state, metabolic demand changes and redirects blood flow to high 
demand tissues. For example, during exercise blood flow is redistributed away from the 
gut to the skeletal muscle, the heart, skin, and the brain (39). Exercise training enforces 
chronic adaptations of increased delivery of oxygen and nutrients, oxidative capacity and 
mitochondrial biogenesis to accommodate the increasing metabolic demands (63). Post 
exercise, blood flow returns to trivial areas, but remains elevated in both skeletal muscle 
and brain at 20% and 14% respectively (39). Exercise is not the only physiological 
stressor that can induce changes in metabolic function and mitochondrial biogenesis; 
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stress originating from the intake of a high fat diet also leads to serious metabolic 
disturbances. 
High fat diet and brain metabolism  
The CNS operates on glucose metabolism within the mitochondria with little to 
no oxidation of fatty acids. Despite this fact, research has shown that a diet high in fat can 
cause metabolic dysregulation not only in peripheral tissues, but central tissues as well. 
Memory deficits and cognitive impairments are the most commonly studied phenomenon 
related to brain function with a HFD. Alzheimer’s and age related dementia are two areas 
of research that have been linked to diet induced obesity and oxidative stress (43, 70). 
The hippocampus has been highly researched in regards to memory deficits and age 
related dementia due to its primary function of memory retrieval, storage and information 
processing. A recent study suggests that memory deficits are correlated to a decline in 
SIRT1 gene expression in the hippocampus of HFD fed mice (28). A decline in SIRT1 
may be indicative of reduced metabolic function and cellular energy production (28). 
Diets high in SF’s and cholesterol have been demonstrated to reduce the integrity of the 
blood brain barrier and cause severe gliosis throughout the hippocampus (21).   
Throughout the brain insulin sensitivity is relatively low compared to skeletal 
muscle; however, in the hypothalamus insulin sensitivity is high allowing mediation of 
systemic hormone regulation. Insulin activity via hypothalamic signaling allows fatty 
acids to be stored in a process called lipogenesis by down regulating the sympathetic 
nervous system output to adipose tissue (59). Hypothalamic injury in accordance with 
excess lipid accumulation will disrupt normal insulin activity and sensitivity and may 
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eventually lead to over production of glucose through gluconeogenic pathways and 
subsequently type 2 diabetes (59). 
Over nutrition by a HFD has been shown to induce mitochondrial dysfunction in 
hypothalamic neurons with a decline in central glucose sensitivity (49).  Morphologic 
measurements of mitochondria post HFD have revealed mitochondrial swelling that 
negated mitochondrial membrane potential, especially during oxidative stress (54). This 
finding suggests that oxidative stress may be leading to mitochondrial dysfunction and a 
decline in energy metabolism preempting metabolic fatigue. Oxidative stress is also a 
primary factor to the induction of inflammation by diet induced obesity and the increase 
in fat cell size and number (5).  
High fat diet and inflammation 
 HFD’s have been shown to take weeks to incite inflammation and dysfunctional 
metabolic regulation in skeletal muscle, however, in the brain it can be observed within 
24 hours, with neuronal injury and impairment in the hypothalamus within the first week 
(66). HFD’s have been shown to cause an increase in adipose tissue, which provides a 
storage site for fat and acts as a production site for inflammatory cytokines such as 
interleukin 1 beta (IL-1β) and tumor necrosis factor alpha (TNF-alpha) (18). As 
adipocytes grow in size and number with a HFD, inflammatory cytokine production 
progressively worsens provoking systemic inflammation. The CNS blocks inflammatory 
cytokines from entering the brain through the blood brain barrier making it immune from 
peripherally instigated inflammation. However, the brain activates various inflammatory 
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transcription factors, increasing cytokines, in response to local and systemic 
inflammation (67). 
TNF-alpha was one of the first major cytokines discovered within the 
inflammatory pathway. Its production from immune cells, skeletal muscle, and adipose 
tissue propagates a wide systemic response. Unlike other pro-inflammatory cytokines, 
TNF-alpha instigates obesity by acting as a potent activator of fatty acid release through 
the NFkB pathway and it inhibits the initiation of receptor substrates for insulin signaling 
(18). Lack of response by insulin can lead to an accumulation of free fatty acids and 
glucose in the blood thereby reducing glycogen storage.  
TNF-alpha is also mediated through IL-1β, a known pro-inflammatory cytokine 
that stimulates the up regulation of other inflammatory cytokines through IL-1 receptor 
signaling thereby activating the NFkB pathway (45). IL-1β has recently been shown in the 
literature to be associated with Alzheimer’s disease progression and other neurological 
disorders by affecting brain astrocytes and neuronal communication (45). Thaler and 
colleges have shown an up regulation of IL-1β and TNF-alpha in response to diet induced 
obesity over 4 weeks (66). Once inflammatory cytokines have infiltrated a tissue the 
overwhelming response is to activate other cytokines to the area stimulating further 
progression of pro-inflammatory processes leading to destruction of a tissue. 
Research has shown that chronic inflammation from HFD’s causes oxidative 
stress instigating the increase in reactive oxygen species (ROS) (2, 7). ROS are common 
byproducts produced during metabolism, but can increase severely during times of 
oxidative stress and mitochondrial damage (39). ROS can also cause mutations in 
37 
 
mtDNA inducing mitochondrial collapse (25).  The inflammatory cascade may be 
involved in every aspect of metabolic oxidative stress due to the chronic inflammatory 
response with a HFD. Current research on HFD’s has developed managerial treatments 
for reducing inflammation and fatigue,  while increasing insulin sensitivity, but no formal 
cures have been discovered. 
Potential treatments  
 Consuming a diet high in fat is well known to cause adiposity and low grade 
chronic inflammation. This inflammation may be the primary cause of insulin 
insensitivity in both the brain and skeletal muscle. HFD induced oxidative stress caused 
by excessive lipid accumulation has also contributed to what seems to be irreversible 
affects on energy metabolism. Improving quality of life and life longevity is the primary 
reason for research on human pathophysiology. Quercetin is a supplement that is found in 
many food sources such as fruits and vegetables and has been shown to work through 
anti-inflammatory pathways (13). Our lab has shown the effective use of Quercetin in 
enhancing brain and muscle mitochondrial biogenesis that stimulated increases in 
endurance capacity and voluntary activity in mice (13).  
Resveratrol is similar to Quercetin in that it is found in common everyday foods 
like red wine and grapes and has been associated with elimination of free radicals and 
reversal of insulin resistance and diet induced obesity (75). Jeon et al. 2012 has shown 
that resveratrol can attenuate inflammation and improve memory deficit in obesity 
induced diabetic mice (31). Resveratrol has also been shown to increase neurogenesis and 
brain-derived neurotrophic factor in the hippocampus (44). 
38 
 
More recently the health community has been trying to implement exercise as a 
prescription for improving health disparity rather than prescribing medication. The 
American College of Sports Medicine has incited “Exercise is Medicine” and continues 
to excite interest in prescribing personalized treatment through exercise. Exercise is 
multifunctional in that several modes exist: resistance training, swimming, running, 
biking, walking, tennis, baseball, etc. producing similar effects allowing subjects to 
choose the most enjoyed form available that is consistently overloading the body to elicit 
adaption. Currently it has been shown that chronic exercise training can attenuate obesity 
related insulin insensitivity by reducing excess lipid accumulation and enhancing 
signaling for glucose uptake and utilization in skeletal muscle (52). 
Conclusion 
In summation, a diet high in fat not only causes peripheral distress, but it also 
causes central dysregulation. The extent of central oxidative stress on metabolic function 
has yet to be fully elucidated. Morphologic observation on mitochondria and changes in 
insulin sensitivity with hypothalamic injury by HFD has been assessed; however, 
regulation of metabolism through enzymatic function has yet to be researched beyond 
SIRT1.  Future research linking obesity to metabolic dysregulation, changes in 
mitochondrial biogenesis, and inflammation is warranted.
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